Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients. [Phase 4]
A Phase 4 study evaluating a medication event monitoring system to improve adherence to Tecfidera in multiple sclerosis was terminated, with…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis [NA]
The clinical trial evaluating the Myelin-TRAP diagnostic tool for multiple sclerosis has been terminated.
-
CLINICAL_TRIALS research · 2017-05-15Clinical Trial Update: An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab [Phase 3]
A clinical trial update describes an extension protocol for patients with relapsing-remitting multiple sclerosis who previously participated…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis [Phase 3]
A Phase 3 trial evaluating L-carnitine versus placebo for fatigue in multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Tecfidera Slow-Titration Study [Phase 3]
A Phase III trial of Tecfidera (dimethyl fumarate) with slow titration in multiple sclerosis was terminated; results were posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis [Phase 1]
Phase 1 trial update on reduced-intensity immunoablation followed by autologous hematopoietic stem cell transplantation for multiple scleros…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Physical Telerehabilitation in Veterans With Multiple Sclerosis [NA]
This update reports that the clinical trial evaluating physical telerehabilitation for veterans with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCI [NA]
This clinical trial update notes a completed study evaluating motivational interviewing to boost physical activity as a treatment for depres…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex [Phase 2]
Phase 2 study evaluating BIIB033 in participants with relapsing forms of multiple sclerosis when used concurrently with Avonex; results have…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis [Phase 1, Phase 2]
This is a completed Phase 1/Phase 2 clinical trial evaluating alpha-lipoic acid and omega-3 fatty acids for cognitive impairment in multiple…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome [Phase 1, Phase 2]
A completed Phase 1/2 trial assessed dose-related effects of Vitamin D3 on immune responses in patients with Clinically Isolated Syndrome an…
-
CLINICAL_TRIALS research · 2017-05-03Clinical Trial Update: Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS [NA]
A clinical trial evaluating whether evidence-based patient information plus smartphone accelerometry can increase physical activity in indiv…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the safety and efficacy of autologous bone marrow–derived mesenchymal stem cells in people with multi…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects [NA]
This completed trial evaluated the effect of melatonin on Sirt1 expression and activity and on its target genes catalase and MnSOD in indivi…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: An Online Self-Guided Meditation Course for Individuals With Multiple Sclerosis [NA]
Completed clinical trial evaluating an online self-guided meditation course for individuals with Multiple Sclerosis.
-
CLINICAL_TRIALS research · 2017-04-26Clinical Trial Update: The Role of Exercise in Modifying Outcomes for People With Multiple Sclerosis [NA]
This clinical trial update discusses the potential impact of exercise on outcomes for people with multiple sclerosis in an ongoing study.
-
CLINICAL_TRIALS withdrawal · 2017-04-25Clinical Trial Update: Improving Memory in Patients With Multiple Sclerosis [Phase 3]
A Phase 3 clinical trial evaluating a memory-improvement intervention for patients with multiple sclerosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-21Clinical Trial Update: Safety and Efficacy of Fingolimod in MS Patients in China [Phase 3]
Clinical trial of fingolimod in relapsing-remitting multiple sclerosis in China was withdrawn during Phase 3.
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis [Phase 2]
A Phase 2 study evaluating 5 weeks of treatment with BGG492 for muscle spasticity in patients with multiple sclerosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against Interferon [Phase 4]
A Phase 4 trial evaluating fingolimod (Gilenya) in patients with neutralizing antibodies against interferon has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Pulse ACTH vs. MP for MS [Phase 1]
Phase 1 trial comparing pulse adrenocorticotropic hormone (ACTH) versus methylprednisolone for multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: ATX-MS-1467 in Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update for ATX-MS-1467 in multiple sclerosis; the study completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Improved Detection of Multiple Sclerosis Plaques in Inversion Recovery by Optimization of Sequence Parameters
A completed clinical trial update reports improved detection of Multiple Sclerosis plaques by optimizing inversion recovery MRI sequence par…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Examining the Effects of Video-game Exercise on Mobility and Brain Plasticity in Individuals With Multiple Sclerosis [NA]
A completed clinical trial at Ohio State University evaluating the effects of video-game-based exercise on mobility and brain plasticity in …
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS
A completed clinical trial investigating the conversion to multiple sclerosis in female monozygotic twins discordant for clinically isolated…